Advertisement

Pharmacy

Under a proposed rule HHS released Jan. 31, drug manufacturers would no longer be able to give rebates to pharmacy benefit managers, but they would be allowed to offer discounted prices directly to consumers.

Medicare Part D beneficiaries with serious health conditions and not receiving low-income subsidies can expect to pay anywhere from $2,622 to $16,551 out of pocket for specialty-tier drugs this year, according to a Kaiser Family Foundation analysis.

Advertisement

Members of the House Energy and Commerce Committee sent letters to three leading insulin manufacturers Jan. 30, inquiring about increasing insulin prices.

Advertisement